Live from the NIH registry
Studies recruiting near Peoria right now
Top 25 of 1,249 recruiting studies, sorted by proximity — each links to its official registry page
Shared Decision Making to Improve Goals of Care in the ED
Goals
N/A
Interventional 230 participants sought
Mayo Clinic in Arizona — Scottsdale, Arizona (29.8 mi)
· Sponsor: Mayo Clinic
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Phoenix Childrens Hospital — Phoenix, Arizona (26.6 mi)
· Sponsor: National Cancer Institute (NCI)
Acceptance and Commitment Therapy and Compassion-Based Virtual Group Therapy to Improve Psychological Wellbeing in Patients With Cancer
Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
N/A
Interventional 200 participants sought
Mayo Clinic in Arizona — Scottsdale, Arizona (29.8 mi)
· Sponsor: Mayo Clinic
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Palo Verde Cancer Specialists ( Site 0105) — Glendale, Arizona (18.2 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Hypertension, Pulmonary, Lung Diseases, Interstitial
Phase 2
Interventional 25 participants sought
Phoenix — Phoenix, Arizona (26.6 mi)
· Sponsor: Tectonic Operating Company, Inc.
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Associated Retina Consultants, Ltd. — Phoenix, Arizona (26.6 mi)
· Sponsor: Boehringer Ingelheim
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Phoenix, Arizona (26.6 mi)
· Sponsor: AstraZeneca
A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
Plasma Cell Myeloma Refractory
Phase 1
Interventional 87 participants sought
Mayo Clinic in Arizona - Phoenix- Site Number : 8400005 — Phoenix, Arizona (26.6 mi)
· Sponsor: Sanofi
Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)
Heavy Menstrual Bleeding
N/A
Interventional 7 participants sought
Arizona Gynecology Consultants — Phoenix, Arizona (26.6 mi)
· Sponsor: Rejoni Inc.
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
Banner Sun Health Research Institute - Cleo Roberts Center for Clinical Research — Sun City, Arizona (13.0 mi)
· Sponsor: Annovis Bio Inc.
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
Severe Tricuspid Regurgitation
N/A
Interventional 1,186 participants sought
Abrazo Arizona Heart Hospital — Phoenix, Arizona (26.6 mi)
· Sponsor: Medtronic Cardiovascular
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
Colorectal Carcinoma
N/A
Interventional 450 participants sought
Mayo Clinic in Arizona — Scottsdale, Arizona (29.8 mi)
· Sponsor: Mayo Clinic
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Advanced Prostate Cancer, Metastatic Prostate Cancer
Phase 1
Interventional 210 participants sought
HonorHealth — Scottsdale, Arizona (29.8 mi)
· Sponsor: Genentech, Inc.
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 4
Interventional 65 participants sought
GI Alliance Sun City — Sun City, Arizona (13.0 mi)
· Sponsor: Takeda
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Acute Myeloid Leukemias
Phase 3
Interventional 468 participants sought
Clinical Trial Site — Goodyear, Arizona (24.4 mi)
· Sponsor: Syndax Pharmaceuticals
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Phase 2
Interventional 100 participants sought
Mayo Clinic - Arizona — Phoenix, Arizona (26.6 mi)
· Sponsor: C4 Therapeutics, Inc.
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Solid Tumors
Phase 2
Interventional 170 participants sought
Local Institution - 0005 — Phoenix, Arizona (26.6 mi)
· Sponsor: Mirati Therapeutics Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
CTCA at Western Regional Medical Center — Goodyear, Arizona (24.4 mi)
· Sponsor: SWOG Cancer Research Network
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
Diabetes Mellitus, Chronic Kidney Diseases
N/A
Observational 500 participants sought
NIDDK-Phoenix Epidemiology and Clinical Research — Phoenix, Arizona (26.6 mi)
· Sponsor: University of New Mexico
Treatment of Moderate to Severe Refractory Crohn's Disease
Crohns Disease
Phase 1, Phase 2
Interventional 39 participants sought
Mayo Clinic Arizona — Scottsdale, Arizona (29.8 mi)
· Sponsor: Tr1X, Inc.
MMA Embolization for Refractory Chronic Migraine
Migraine Disorders
N/A
Interventional 70 participants sought
Barrow Neurological Institute at St. Joseph's Hospital — Phoenix, Arizona (26.6 mi)
· Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Phoenix, Arizona (26.6 mi)
· Sponsor: Sameek Roychowdhury
ELEVATE High-Risk PCI Pivotal Study
High-Risk Percutaneous Coronary Intervention (High-risk PCI)
N/A
Interventional 290 participants sought
Banner-University Medical Center — Phoenix, Arizona (26.6 mi)
· Sponsor: Magenta Medical Ltd.
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers — Glendale, Arizona (18.2 mi)
· Sponsor: Pfizer
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
Myeloid Malignancy, Inherited Bone Marrow Failure Syndrome
N/A
Interventional 2,000 participants sought
Mayo Clinic in Arizona — Scottsdale, Arizona (29.8 mi)
· Sponsor: Mayo Clinic